‘Anonymous’ genetic databases vulnerable to privacy leaks
By Helena Kudiabor,
Nature
| 10. 14. 2024
A study has raised concerns that a type of genetic database that is increasingly popular with researchers could be exploited to reveal the identities of its participants, or link private health information to their public genetic profiles.
Single-cell data sets can contain information on gene expression in millions of cells collected from thousands of people. They are often freely accessible, providing a valuable resource for researchers who study the effects of diseases at a cellular level. The data are supposed to be anonymized, but a study published on 2 October in Cell1 shows how genetic data from one study “can be exploited to uncover private information about individuals in another study”, the authors write.
The findings highlight the difficulty of balancing the interests of researchers with the privacy of donors. “Our genomes are very identifying. They can tell a lot about us, our traits, our predisposition to diseases,” says study co-author Gamze Gürsoy, a bioinformatics researcher at Columbia University in New York City. “You can change your credit-card number if it leaks, but you cannot change your genome.”
Sensitive
...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...